Hemophilia
Odporúčame
Neutralizing Antibodies Against Emicizumab – Detailed Analysis Based on a Case Study
Japanese authors investigated the mechanism of reduced efficacy of emicizumab in an adult patient with hemophilia A and an inhibitor, whose treatment was discontinued due to repeated bleeding episodes with prolonged aPTT.
V tejto sekcii aktuálne neponúkame žiadny obsah.
Prihlásiť na odber spravodajcu
Kurzy k tejto téme
Najčítanejšie k tejto téme
Časopis k tejto téme
Súvisiace témy
Zaujímavé odkazy